Filter by

CIO Reflections: Q2 2023

On May 11th , 2023 , Tema launched its first three funds.

Revolutionizing Cancer Treatment: Antibody-Drug Conjugates (ADCs)

Antibody-Drug Conjugates (ADCs) are a powerful fusion of biological engineering and modern medicine. They employ precisely engineered antibodies...

Tema expands its life sciences fund suite with the Tema Neuroscience and Mental Health ETF (MNTL)

Tema ETFs (“Tema”) is excited to announce the launch of its Tema Neuroscience and Mental Health ETF (MNTL), on Nasdaq. MNTL is the first actively...

Neuroscience and Mental Health: the most unmet need in life sciences

By many measures, neurological disorders remain the final frontier of life science research. Recent breakthroughs offer hope that we are at a turning...

Cell therapies - Revolutionizing Cancer Treatment

In oncology, cell therapy is a groundbreaking approach that involves using engineered immune cells, often sourced from the patient, as a "living...

The Proliferation of Royalties in Non-Commodity Sectors

Royalties were invented in the commodity industry to finance the development of mines around the world. Yet this innovative financing structure has...

Artificial Intelligence (AI) and Incumbent Data Moats

Artificial intelligence in the form of natural language models burst onto the scene with the launch of Chat GPT from Open AI, which gained 1 million...

The Next Generation of Cardiovascular Drugs

The cardiometabolic space is more than just the obesity revolution. Although GLP-1 weight loss drugs, like Wegovy, could modify cardiovascular...

Private Sector Roots to Shine Through in an Election Year

As we enter an election year in 2024, the trend that we are hearing most from firms is how reshoring is increasingly being made as an independent...

Luxury Auto Industry Insights - Dr. Philip Koehn

Watch our latest interview of Dr. Philip Koehn, an auto industry veteran, to learn about the exciting investment opportunities within the rapidly...

Liquid Biopsies - Revolutionizing Cancer Diagnosis

Liquid biopsies, a cutting-edge diagnostic tool, are changing the landscape of cancer detection. They harness bodily fluids, such as blood, to...

2023 Rewind: 26 Key Insights from Last Year

From technological leaps to socio-economic shifts, we unwind the key highlights of this year that will define the landscape of 2024 and the years...

Investing in the diabesity epidemic: a breakthrough moment

Cardiovascular and metabolic diseases are a vast chronic burden on patients and society and the leading cause of death globally[1]. However, recent...

Tema launches its second targeted healthcare fund: the Tema Cardiovascular and Metabolic ETF (HRTS)

Tema ETFs (“Tema”) is excited to announce the launch of its actively managed Tema Cardiovascular and Metabolic ETF (HRTS), on Nasdaq. HRTS is the...

Investor's Guide to the Oncology Revolution Webinar Replay

Watch our latest webinar to learn about the exciting investment opportunities and challenges within the rapidly evolving field of cancer therapeutics...

Tema Trends: Exploring Monopoly, Luxury ETFs and Reshoring Insights

In this edition of Tema Trends we: Ask ourselves whether the rapidly evolving technology sector has the potential to create enduring...

Universal & Deezer deal: good for music publishers, great for artists, fantastic for royalties

Music royalties are currently structured so that listeners’ monthly subscription fees are pooled together into one royalty pot that is divided among...

Luxury ETF Giving US investors access to hard-to-access Luxury stocks

In the past decade, advances in technology have significantly improved individual investor’s ability to participate in the stock market. This was...

Tema launches actively managed Global Royalties ETF

Tema ETFs (“Tema”) launches the actively managed Tema Global Royalties ETF (ROYA), the only ETF listed in the United States focused on royalties....

Investing in royalties: commodities, private assets & real contractual income

Royalties stand out in the equity investment landscape by offering a combination of three areas -commodities, private assets, and income generation....

Tema launches actively managed oncology ETF: investing in the cancer life-science revolution

Tema ETFs (“Tema”) launches the Tema Oncology ETF (CANC), the first actively managed ETF listed in the United States seeking to provide long-term...

Investing in oncology: a biotech revolution in research, diagnosis, and treatment of cancer

Cancer will affect one in every two people in their lifetime. Yet, oncology is on the brink of a revolution, which we expect will trigger a material...

Thematic ETFs: overcoming performance anxiety through purity of exposure

We are all being measured. Constantly. From the time we are born and the doctor wrote down our height and weight for our birth announcements, to the...

Why American Reshoring extends beyond US infrastructure

The start of this decade has been marked by impactful events which have unleashed a wave of change that is increasingly touching the American...

Introduction to thematic investing

What is thematic investing? While the formal appearance of thematic investing occurred around World War II, the practice of identifying and investing...

The risks of investing in luxury through an indexed passive vehicle

In our introduction to luxury blog, we touched on the potential limitations of investing in the luxury sector through an index approach. In this...

Monopolies: how Tema seeks to identify and invest in moat-like businesses

Many equity investors now know that quality and competitive advantage (moats1) matters. However, identifying firms that can sustain these for the...

Reshoring megatrend: how to invest in the new era of American manufacturing

Major economic undercurrents, like the development of electric power or the microprocessor, often build and come to the surface as megatrends,...

Investing in timeless elegance: the case for luxury stocks

The global luxury market is home to iconic brands and outstanding businesses. This blog explores why the luxury sector stands out by the nature of...

Tema launches three active ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies

Tema launches three innovative, professionally managed thematic ETFs: American Reshoring, Luxury, & Monopolies and Oligopolies Tema ETFs (“Tema”)...

No results found